icad inc. (NASDAQ:ICAD) is set to announce second quarter earning results on Tuesday 4th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, ICAD to report 2Q20 loss of $ 0.22 per share.
For the full year, analysts anticipate top line of $ 24.85 million, while looking forward to loss of $ 0.69 per share bottom line.
Previous Quarter Performance
icad inc. came out with loss for the first quarter of $ 0.20 per share, from the revenue of $ 6.55 million. Wall street analysts are predicting, ICAD to report 1Q20 loss of $ 0.13 per share from revenue of $ 7.71 million. The bottom line results missed street analysts by $ 0.07 or 53.85 percent, at the same time, top line results fell short of analysts by $ 1.16 million or 15.05 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of icad inc.
Stock Performance
According to the previous trading day, closing price of ICAD was $ 9.68, representing a 76.00 % increase from the 52 week low of $ 5.50 and a 36.77 % decrease over the 52 week high of $ 15.31.
The company has a market capital of $ 221.22 million and is part of the Technology sector and Health Information Services industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”ICAD” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
icad inc. will be hosting a conference call at 4:30 PM eastern time on 4th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.icadmed.com
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy.
